BioSenic provides update on its autoimmune disease platform

BIOSENIC Euronext Brussels and Paris: BIOS), the company specialized in serious autoimmune inflammatory diseases and cell repair, today announces an update on its systemic autoimmune disease... | November 9, 2022

Related Keywords

Boston , Massachusetts , United States , Dana Farber Cancer Institute , Paris , France General , France , Francois Rieger , Corey Cutler , Catherine Haquenne , Ann Reum , Medsenic Biosenic , Harvard Medical School , Stem Cell Transplantation Program , Euronext Brussels , Host Disease , Arsenic Trioxide , Farber Cancer Institute , Graft Versus Host , Market Access , Chronic Graft , Systemic Lupus , Systemic Sclerosis , News Publishing , Biosenic Sa Stock Exchange , News , Information , Press Release , Biosenic , Uronext , Brussels , End , The , Company , Specialized , N , Serious , Autoimmune , Inflammatory , Diseases , Fell , Oday , Nnounces , Update , Its , Systemic , Utoimmune Bios Be0974280126 ,